Tony Jiménez-Beristáin

Tony Jimenez‑Beristain is a neuroscientist and research coordinator at Karolinska Institutet. He studied Chemistry, Biology, and Pharmacy at the  UAA (Mexico), graduating in 2001. He obtained his PhD in Neuroscience in 2007 from Miguel Hernández University (Alicante, Spain), where he conducted his doctoral research at the Institute of Neuroscience (IN‑CSIC, Alicante).

During his PhD, carried out in the research groups of Professor Carmen de Felipe (IN‑CSIC, Spain) and Professor Li (Institute for Stem Cell Research, University of Edinburgh, Scotland), he investigated the role of the transcription factor Pitx3 in the differentiation and commitment of embryonic stem cells toward midbrain dopaminergic neurons, as well as their potential application in cell replacement therapies for Parkinson’s disease. His doctoral work was awarded summa cum laude and the Doctor Europaeus distinction by the European University Association.

Following his doctoral studies, he undertook postdoctoral training at Uppsala University’s Biomedical Centre, then he joined the Human Protein Atlas project at SciLifeLab in Stockholm and subsequently incorporated into Karolinska Institutet.

In addition to his research activities, Tony Jimenez‑Beristain serves as an ethics review panel coordinator and scientific member of the Stockholm County Animal Ethics Board. Since 2011, he has also held roles as Safety and Security Officer at SciLifeLab (Stockholm site) and within the Departments of Physiology and Pharmacology, and Medical Biochemistry and Biophysics at Karolinska Institutet.

Honours:
2015 Nominated for the 2015 Karolinska Institute’s work environment 
and health award (Sweden)
2015 Elected by direct vote, Stockholm’s delegate in the 2015 national 
Congress. Swedish Association of Professional Scientists /Naturvetarna/ 
(Sweden)
2007 Doctoral thesis awarded “Doctor Europaeus” by the European 
Universities Association (European Union)
2004 - 2006 Spanish Ministry of Education and Science doctorate 
grant (Spain)